简易衰弱工具集在老年心衰患者中的临床与预后价值
本研究基于FRAGILE-HF多中心观察性队列,纳入1237例≥65岁住院心衰患者,按简易衰弱工具集(EFT)评分分为强壮、衰弱前期和衰弱三组。中位随访2年发生256例死亡,衰弱组较强壮组全因死亡风险显著升高(aHR 2.01,95%CI 1.12-3.61,p=0.019),EFT评分作为连续变量亦与死亡风险相关(aHR 1.19,95%CI 1.08-1.31,p<0.001)。
要点
- EFT评分越高,Fried表型判定的衰弱患病率越高(p<0.001)。
- EFT衰弱组2年全因死亡风险约为强壮组的2倍。
- EFT加入传统风险模型可改善连续净重分类。
核心结论
- EFT在老年心衰患者中具有临床与预后评估价值。
- EFT评分与2年全因死亡风险独立相关,且可改善风险重分类。
研究设计与样本
- 多中心观察性研究,使用FRAGILE-HF队列中≥65岁住院心衰患者数据。
- 共纳入1237例患者,年龄80.1±7.1岁,女性占43%。
- EFT包含五次坐立试验、认知功能评估及血红蛋白和白蛋白测量,按0分、1-2分、3-5分分为强壮、衰弱前期和衰弱组。
主要发现
- 强壮、衰弱前期和衰弱组分别占11.6%、49.0%和39.4%。
- Fried表型判定的衰弱患病率随EFT评分升高而增加(p<0.001)。
- 2年随访期间共发生256例死亡。
- 衰弱组较强壮组主要终点风险显著升高(aHR 2.01,95%CI 1.12-3.61,p=0.019)。
- EFT评分作为连续变量与主要终点显著相关(aHR 1.19,95%CI 1.08-1.31,p<0.001)。
关键数值与推荐
- EFT分组:强壮0分,衰弱前期1-2分,衰弱3-5分。
- 主要终点为2年全因死亡率。
- 将EFT分组加入传统风险模型后观察到显著的连续净重分类改善。
临床怎么用
- 对住院老年心衰患者可采用EFT进行简单客观的衰弱评估以辅助预后分层。
- EFT评分较高的患者死亡风险更高,可能需更密切的随访与管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Heart failure (HF) is associated with frailty, and most frailty assessment methods are subjective and complex. The Essential Frailty Toolset (EFT) is a simple, objective, and comprehensive frailty assessment tool. This study aimed to investigate the clinical and prognostic values of the EFT in patients with HF. METHODS: Data from a multicenter, observational study on older (≥ 65 years old) patients hospitalized with HF, the FRAGILE-HF cohort, was used. The EFT includes a five-time chair stand test, cognitive function assessment, and hemoglobin and albumin measurements. Patients were divided into three groups based on their EFT points: robust (0 points), pre-frail (1-2 points), and frail (3-5 points). The primary endpoint was 2-year all-cause mortality. RESULTS: Of the total 1237 patients (80.1 ± 7.1 years; 43% females), the robust, pre-frail, and frail groups included 114 (11.6%), 606 (49.0%), and 487 (39.4%) patients, respectively. The prevalence of frailty, evaluated using the Fried phenotype model, increased with increased EFT points (p < 0.001). Within the 2-year follow-up period, 256 deaths occurred. The frail group was significantly associated with a higher risk of the primary endpoint than the robust group (adjusted hazard ratio [aHR], 2.01; 95% confidence interval [CI], 1.12-3.61; p = 0.019). The EFT point, as a continuous variable, was significantly associated with the primary endpoint (aHR, 1.19; 95% CI, 1.08-1.31; p < 0.001). A significant continuous net reclassification improvement was observed when the EFT groups were added to the conventional risk model. CONCLUSION: The EFT demonstrated valuable clinical and prognostic value in older patients with HF.
引用
- Maeda D, Matsue Y, Kagiyama N, et al. Clinical and Prognostic Utility of the Essential Frailty Toolset in Older Patients With Heart Failure. J Am Geriatr Soc. 2025. PMID: 40981616. doi:10.1111/jgs.70103
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。